Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients? (Q44570490)

4 December 2017

Rabbit antithymocyte globulin: a postoperative risk factor for sirolimus-treated renal transplant patients? (English)

1 reference

4 December 2017

C Benavides

1

1 reference

4 December 2017

K H Mahmoud

2

1 reference

4 December 2017

R Knight

3

1 reference

4 December 2017

C Barcenas

4

1 reference

4 December 2017

B D Kahan

5

1 reference

4 December 2017

C T Van Buren

6

1 reference

4 December 2017

language of work or name

English

0 references

publication date

1 March 2005

1 reference

Transplantation Proceedings

4 December 2017

1 reference

4 December 2017

37

1 reference

4 December 2017

2

1 reference

4 December 2017

822-826

1 reference

Efficacy of sirolimus compared with azathioprine for reduction of acute renal allograft rejection: a randomised multicentre study

4 December 2017

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Sirolimus reduces the incidence of acute rejection episodes despite lower cyclosporine doses in caucasian recipients of mismatched primary renal allografts: a phase II trial. Rapamune Study Group

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Dyslipidemia in renal transplant recipients treated with a sirolimus and cyclosporine-based immunosuppressive regimen: incidence, risk factors, progression, and prognosis

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Sirolimus-induced thrombocytopenia and leukopenia in renal transplant recipients: risk factors, incidence, progression, and management

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Higher surgical wound complication rates with sirolimus immunosuppression after kidney transplantation: a matched-pair pilot study

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Comparison of sirolimus vs. mycophenolate mofetil on surgical complications and wound healing in adult kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Incidence, therapy, and consequences of lymphocele after sirolimus-cyclosporine-prednisone immunosuppression in renal transplant recipients

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Hypoxia enhances vascular cell proliferation and angiogenesis in vitro via rapamycin (mTOR)-dependent signaling

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

Wound-healing complications after kidney transplantation: a prospective, randomized comparison of sirolimus and tacrolimus

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

The effect of in vivo T helper and T suppressor lymphocyte depletion on wound healing

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

The influence of various maintenance immunosuppressive drugs on lymphocele formation and treatment after kidney transplantation

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

The selective use of basiliximab versus thymoglobulin in combination with sirolimus for cadaveric renal transplant recipients at low risk versus high risk for delayed graft function

7 January 2021

1 reference

https://api.crossref.org/works/10.1016%2FJ.TRANSPROCEED.2004.12.121

10.1016/J.TRANSPROCEED.2004.12.121

7 January 2021

Identifiers

DOI

1 reference

4 December 2017

1 reference